Hospital
ST. Vincent's Medical Center-Clay County, INC.
ST. Vincent's Medical Center-Clay County, INC. was paid $5.82M by Medicaid between Jan 2018 and Nov 2024, across 145 billing codes. Its largest line is 99285, emergency room visit (most serious) — 26% of everything it billed.
33Billing provider infoST. VINCENT'S MEDICAL CENTER-CLAY COUNTY, INC.
MIDDLEBURG, FL 32068
MIDDLEBURG, FL 32068
33aNPI1457690471assigned 02/12/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.82M
24GClaims205,485
24DCodes billed145
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#76 of 163
Median peer was paid$4.77M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,952 | $375K | |
| 2019 | 47,981 | $1.09M | |
| 2020 | 37,172 | $924K | |
| 2021 | 43,054 | $1.33M | |
| 2022 | 46,429 | $1.56M | |
| 2023 | 10,312 | $493K | |
| 2024incomplete | 585 | $49K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26% | 14,728 | 12,581 | $1.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 9,128 | 8,277 | $711K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 7,093 | 6,639 | $640K |
| 36415 | Collection of venous blood by venipuncture | 5.2% | 10,949 | 8,284 | $301K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 4,296 | 3,941 | $245K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.9% | 1,074 | 976 | $227K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.8% | 1,191 | 1,051 | $218K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 5,315 | 4,941 | $170K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.4% | 2,180 | 1,958 | $140K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 2,574 | 2,224 | $140K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.4% | 3,145 | 2,686 | $139K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.2% | 1,242 | 1,125 | $126K |
133 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 1,411 | $122K |
| 80053 | Comprehensive metabolic panel | 1.4% | 8,272 | $83K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 699 | $64K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,632 | $55K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,251 | $54K |
| 80047 | <1% | 2,848 | $46K | |
| A9270 | Non-covered item or service | <1% | 3,940 | $43K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 854 | $41K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,144 | $40K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 190 | $40K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,424 | $31K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 487 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,927 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,191 | $26K |
| 87400 | <1% | 2,064 | $25K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,431 | $25K |
| G0378 | Hospital observation service, per hour | <1% | 2,230 | $25K |
| 87081 | <1% | 869 | $25K | |
| 81001 | <1% | 5,994 | $22K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 630 | $22K |
| 81002 | <1% | 1,606 | $21K | |
| 82962 | <1% | 1,725 | $20K | |
| 73630 | <1% | 735 | $18K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 654 | $17K |
| 73130 | <1% | 407 | $16K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,632 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,581 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,195 | $13K |
| 84484 | <1% | 4,877 | $13K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,138 | $13K |
| 81025 | <1% | 3,185 | $11K | |
| 76830 | Ultrasound, transvaginal | <1% | 699 | $11K |
| 81003 | <1% | 2,127 | $11K | |
| 73610 | <1% | 348 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,129 | $11K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 26 | $10K |
| J2704 | Injection, propofol, 10 mg | <1% | 956 | $10K |
| 73562 | <1% | 485 | $10K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,503 | $9K |
| 71250 | <1% | 196 | $9K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,505 | $9K |
| 93017 | <1% | 268 | $8K | |
| 86901 | <1% | 835 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,277 | $7K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 68 | $7K |
| 96376 | <1% | 704 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 80 | $6K |
| 85610 | <1% | 1,438 | $6K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,844 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,178 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 171 | $5K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,837 | $5K |
| 93971 | <1% | 289 | $4K | |
| 73030 | <1% | 249 | $4K | |
| 59025 | Fetal non-stress test | <1% | 40 | $4K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 29 | $3K |
| 84112 | <1% | 99 | $3K | |
| 85730 | <1% | 1,025 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 591 | $3K |
| 86850 | <1% | 204 | $3K | |
| 83690 | <1% | 3,119 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,175 | $3K |
| 12001 | <1% | 15 | $3K | |
| 83880 | <1% | 852 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 425 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 190 | $3K |
| 80076 | <1% | 1,005 | $2K | |
| 76801 | <1% | 305 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 213 | $2K |
| 76770 | <1% | 55 | $2K | |
| 84702 | <1% | 933 | $2K | |
| 86900 | <1% | 391 | $2K | |
| 73110 | <1% | 72 | $2K | |
| 87430 | <1% | 904 | $2K | |
| 74018 | <1% | 99 | $2K | |
| 85014 | <1% | 1,043 | $2K | |
| 93970 | <1% | 46 | $1K | |
| 72110 | <1% | 162 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 301 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 42 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 41 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 117 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 960 | $1K |
| 87807 | <1% | 260 | $1K | |
| 84703 | <1% | 2,232 | $1K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 29 | $742.00 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 46 | $728.89 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 559 | $724.29 |
| 72040 | <1% | 12 | $654.76 | |
| 87210 | <1% | 89 | $478.45 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 30 | $415.17 |
| 87634 | <1% | 617 | $351.30 | |
| 80061 | Lipid panel | <1% | 89 | $348.29 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 704 | $320.62 |
| 74021 | <1% | 13 | $283.94 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 245 | $250.73 |
| 87186 | <1% | 101 | $168.20 | |
| 70486 | <1% | 12 | $148.80 | |
| 82247 | <1% | 57 | $126.24 | |
| 99406 | <1% | 74 | $98.22 | |
| 72072 | <1% | 15 | $83.20 | |
| 83605 | <1% | 1,017 | $82.46 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 154 | $79.84 |
| 36416 | <1% | 20 | $79.03 | |
| 85027 | <1% | 29 | $68.24 | |
| 85379 | <1% | 85 | $67.74 | |
| 83735 | <1% | 1,093 | $53.58 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 30 | $45.83 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 440 | $32.09 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 514 | $30.88 |
| 82248 | <1% | 57 | $8.97 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 32 | $3.13 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 190 | $0.00 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 12 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 30 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 26 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 19 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 16 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 12 | $0.00 |
| 87147 | 0% | 105 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 55 | $0.00 |
| 82077 | 0% | 38 | $0.00 | |
| 80320 | 0% | 28 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 47 | $0.00 |
| 87040 | 0% | 60 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 186 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 91 | $0.00 |
| 85652 | 0% | 30 | $0.00 | |
| 83615 | 0% | 15 | $0.00 | |
| 80329 | 0% | 25 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 14 | $0.00 |
| 87077 | 0% | 16 | $0.00 | |
| 82550 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHISHOLM, MOODY (PRESIDENT)